Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients

Cancer

Volumn 121, Issue S17, 2015, Pages 3113-3121

  Yang, Da Wei ^a,b   Zhang, Yong ^a,b   Hong, Qun Ying ^a,b   Hu, Jie ^a,b   Li, Chun ^a,b   Pan, Bai Shen ^a   Wang, Qun ^a   Ding, Fei Hong ^a   Ou, Jia Xian ^a   Liu, Fang Lei ^a   Zhang, Dan ^a   Zhou, Jie Bai ^a   Song, Yuan Lin ^a,b   Bai, Chun Xue ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Research Institute   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

biomarker; delayed diagnosis; non small cell lung cancer; progastrin releasing peptide (ProGRP); small cell lung cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; PROGASTRIN RELEASING PEPTIDE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; ANTIGEN CYFRA21.1; CYTOKERATIN 19; PEPTIDE FRAGMENT; PRO-GASTRIN-RELEASING PEPTIDE (31-98); RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FALSE NEGATIVE RESULT; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMALL CELL LUNG CANCER; BLOOD; CHINA; MIDDLE AGED; PATHOLOGY;

AGED; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KERATIN-19; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SERPINS; SMALL CELL LUNG CARCINOMA;

EID: 84940666898     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29551     Document Type: Article

References (48)

1. Bray F, Ren JS, Masuyer E, Ferlay J,. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013; 132: 1133-1145.
2. Yang GH, Huang ZJ, Tan J,. Priorities of disease control in China-analysis on mortality data of National Disease Surveillance Points System [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 1996; 17: 199-202.
3. Yang GH, Hu JP, Rao KQ, Ma J, Rao C, Lopez AD,. Mortality registration and surveillance in China: history, current situation and challenges. Popul Health Metr. 2005; 3: 3.
4. Godtfredsen NS, Prescott E, Osler M,. Effect of smoking reduction on lung cancer risk. JAMA. 2005; 294: 1505-1510.
5. National Office for Cancer Prevention and Control. Beijing, China: People's Medical Publishing House; 2010.
6. Li YQ, Dai M, Chen YL, et al., Estimates of lung cancer mortality at the province level in China [in Chinese]. Zhongguo Fei Ai Za Zhi. 2011; 14: 120-126.
7. Ezzati M, Lopez AD,. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003; 362: 847-852.
8. Ezzati M, Henley SJ, Lopez AD, Thun MJ,. Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer. 2005; 116: 963-971.
9. Youlden DR, Cramb SM, Baade PD,. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol. 2008; 3: 819-831.
10. Bray FI, Weiderpass E,. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer. 2010; 126: 1454-1466.
11. Currie GP, Kennedy AM, Denison AR,. Tools used in the diagnosis and staging of lung cancer: what's old and what's new? QJM. 2009; 102: 443-448.
12. Salomaa ER, Sallinen S, Hiekkanen H, Liippo K,. Delays in the diagnosis and treatment of lung cancer. Chest. 2005; 128: 2282-2288.
13. Olesen F, Hansen RP, Vedsted P,. Delay in diagnosis: the experience in Denmark. Br J Cancer. 2009; 101: S5-S8.
14. Sulu E, Tasolar O, Berk Takir H, Yagci Tuncer L, Karakurt Z, Yilmaz A,. Delays in the diagnosis and treatment of non-small-cell lung cancer. Tumori. 2011; 97: 693-697.
15. Brocken P, Kiers BA, Looijen-Salamon MG, et al., Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning. Lung Cancer. 2012; 75: 336-341.
16. Goldstraw P, Crowley J, Chansky K, et al., The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007; 2: 706-714.
17. Howlader N, Noone AM, Krapcho M, eds. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
18. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al., Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
19. Li LY, Gao T, Zu N, Huang XM,. Analysis of 847 cases of lung cancer diagnosis flow [in Chinese]. Zhonghua Nei Ke Za Zhi. 2000; 39: 270-271.
20. Feng SL,. 158 cases of first symptom in lung cancer patients and analysis of diagnosis delay [in Chinese]. Lin Chuang Hui Cui. 2000; 15: 610.
21. Zhang GJ,. Clinical analysis of 107 cases diagnosis flow of lung cancer [in Chinese]. Zhongguo Zong He Lin Chuang. 2003; 19: 576.
22. Luo GG, Deng ZM, Wang BQ,. Diagnosis of 78 cases of bronchial carcinoma [in Chinese]. J Fourth Mil Med Univ. 2004; 25: 832.
23. Peng H, Han BH, Li XQ, Tao LN,. Analysis of clinical characteristics and survival rates in 1279 lung cancer patients [in Chinese]. Zhongguo Ai Zheng Za Zhi. 2011; 21: 354-358.
24. Wang ZP, Zhang HP, Sun Y,. The analysis of misdiagnosis among 941 lung cancer patients and some suggestions to avoid the misdiagnosis [in Chinese]. Zhongguo Zhong Liu Lin Chuang. 2000; 27: 582-586.
25. Gao QY, Zhang CZ, Zhou PH,. Reason analysis of 65 cases of lung cancer misdiagnosed as tuberculosis [in Chinese]. Zhongguo Fang Lao Za Zhi. 2002; 24: 307.
26. Wang LP, Mei QD, Gao GQ, Pan QX,. Reason analysis of 126 diagnosis flow in elder lung cancer patients [in Chinese]. Zhengzhou Da Xue Xue Bao Yi Xue Ban. 2003; 38: 438-439.
27. Berlin NI, Buncher CR, Fontana RS, Frost JK, Melamed MR,. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: introduction. Am Rev Respir Dis. 1984; 130: 545-549.
28. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N,. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis. 1984; 130: 555-560.
29. Fontana RS, Sanderson DR, Taylor WF, et al., Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984; 130: 561-565.
30. Frost JK, Ball WC Jr, Levin ML, et al., Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984; 130: 549-554.
31. Koga H, Eguchi K, Shinkai T, et al., Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patients. Jpn J Clin Oncol. 1994; 24: 263-268.
32. Moro D, Villemain D, Vuillez JP, Delord CA, Brambilla C,. CEA, CYFRA21-1 and SCC in non-small cell lung cancer. Lung Cancer. 1995; 13: 169-176.
33. Kohno N, Hirasawa Y, Kondo K, et al., Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma. Cancer Detect Prev. 1997; 21: 124-128.
34. Molina R, Auge JM, Bosch X, et al., Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology. Tumour Biol. 2009; 30: 121-129.
35. Zheng Y, Wu CX, Bao PP, et al., Incidences and time trends of lung cancer in Shanghai during the last 33 years. J Diagn Concepts Pract. 2006; 5: 126-130.
36. Metz CE,. Basic principles of ROC analysis. Semin Nucl Med. 1978; 8: 283-298.
37. Ou SH, Zell JA,. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol. 2009; 4: 1202-1211.
38. Swensen SJ, Jett JR, Hartman TE, et al., Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003; 226: 756-761.
39. Bastarrika G, Garcia-Velloso MJ, Lozano MD, et al., Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med. 2005; 171: 1378-1383.
40. Gohagan JK, Marcus PM, Fagerstrom RM, et al., Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005; 47: 9-15.
41. Jeong YJ, Lee KS, Jeong SY, et al., Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology. 2005; 237: 675-683.
42. Vierikko T, Jarvenpaa R, Autti T, et al., Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur Respir J. 2007; 29: 78-84.
43. Jett JR,. Spiral computed tomography screening for lung cancer is ready for prime time. Am J Respir Crit Care Med. 2001; 163: 812-813.
44. Tiitola M, Kivisaari L, Huuskonen MS, et al., Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer. 2002; 35: 17-22.
45. Mastrangelo G, Ballarin MN, Bellini E, et al., Feasibility of a screening programme for lung cancer in former asbestos workers. Occup Med (Lond). 2008; 58: 175-180.
46. Toyoda Y, Nakayama T, Kusunoki Y, Iso H, Suzuki T,. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer. 2008; 98: 1602-1607.
47. Molina R, Filella X, Auge JM,. ProGRP: a new biomarker for small cell lung cancer. Clin Biochem. 2004; 37: 505-511.
48. Molina R,. ProGRP: a new biomarker for small cell lung cancer. Eur J Clin Med Oncol. 2009; 1: 25-32.